I appreciate that now we've got all the cards on the table, because one of the previous speakers was speaking to Quebec, the efficiency that's seen down there and the number of drugs that are available. And it jumped out at me when I heard the comment that this was also a province where a good number of pharmaceutical companies are located.
I'm just concerned that there's an underlying current here that could be interpreted as pharmaceutical influence in both of those cases. So I'm the type who likes to see things on the table, so to speak.
Dr. Lexchin, would you like to respond further, or do you feel you've completed that?